AEMD:XETRA:XETRA-Amundi Index Solutions - Amundi Index MSCI Emerging Markets UCITS ETF DR EUR (EUR)

ETF | Others |

Last Closing

USD 48.172

Change

+0.08 (+0.17)%

Market Cap

USD 0.32B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.37 (+0.84%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.23 (+0.25%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.12 (+0.51%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.07 (+0.56%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.04 (+0.73%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.15 (+0.66%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.02 (+0.15%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.76 (+1.35%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.03 (+0.34%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.16 (-0.13%)

USD 12.26B

ETFs Containing AEMD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.76% 48% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.76% 52% F 48% F
Trailing 12 Months  
Capital Gain -1.31% 31% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.31% 34% F 37% F
Trailing 5 Years  
Capital Gain 12.40% 35% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.40% 36% F 37% F
Average Annual (5 Year Horizon)  
Capital Gain 1.05% 28% F 31% F
Dividend Return 2.84% 36% F 37% F
Total Return 1.78% 88% B+ 67% D+
Risk Return Profile  
Volatility (Standard Deviation) 12.21% 51% F 60% D-
Risk Adjusted Return 23.25% 30% F 35% F
Market Capitalization 0.32B 62% D 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.